APA (7th ed.) Citation

Liu, D., Wei, H., Hu, Y., Wang, H., Li, P., Lu, K., . . . Li, Z. (2025, October). Case Report: CD19 and CD22 CAR-T therapy induced durable complete remission in a patient with refractory plasmablastic lymphoma. Frontiers in Immunology.

Chicago Style (17th ed.) Citation

Liu, Dan, Haichen Wei, Yanran Hu, Hui Wang, Ping Li, Ke Lu, Wenjun Zhang, Lijie Xing, and Zengjun Li. "Case Report: CD19 and CD22 CAR-T Therapy Induced Durable Complete Remission in a Patient with Refractory Plasmablastic Lymphoma." Frontiers in Immunology Oct. 2025.

MLA (9th ed.) Citation

Liu, Dan, et al. "Case Report: CD19 and CD22 CAR-T Therapy Induced Durable Complete Remission in a Patient with Refractory Plasmablastic Lymphoma." Frontiers in Immunology, Oct. 2025.